Fulcrum Therapeutics, Inc.·4

Dec 7, 4:30 PM ET

Ezekowitz Alan 4

4 · Fulcrum Therapeutics, Inc. · Filed Dec 7, 2020

Insider Transaction Report

Form 4
Period: 2020-12-03
Transactions
  • Award

    Stock Option (right to buy)

    2020-12-03+15,00015,000 total
    Exercise: $11.82Exp: 2030-12-02Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]This option was granted on December 3, 2020 and is scheduled to vest with respect to all shares on November 2, 2021, subject to continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION